Edition:
United Kingdom

Bayer Statement On Voluntary Recall Of Two Lots Of Kogenate FS Antihemophilic Factor In U.S.


Friday, 19 Jul 2019 

July 19 (Reuters) - Bayer::BAYER STATEMENT ON VOLUNTARY RECALL OF TWO LOTS OF KOGENATE® FS ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN THE UNITED STATES.BAYER - THERE ARE NO LOTS OF JIVI OR KOVALTRY(®) ANTIHEMOPHILIC FACTOR (RECOMBINANT) PRODUCT AFFECTED BY RECALL.BAYER-WHILE MAJORITY OF MISLABELED VIALS IN AFFECTED LOTS WERE RECOVERED,ABOUT 990 OF VIALS IN U.S. ASSOCIATED JIVI BATCH EXPIRED ASOF AUG 2018.BAYER - VIALS OF KOGENATE FS THAT ARE NOT ASSOCIATED WITH AFFECTED LOT NUMBERS ARE NOT IMPACTED.